Optimal Glycated Hemoglobin Cutoff for Diagnosis of Diabetes and Prediabetes in Chinese Breast Cancer Women

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Wang L, Peng W, Zhao Z, et al. Prevalence and treatment of diabetes in China, 2013–2018. JAMA. 2021;326(24):2498–2506. doi:10.1001/jama.2021.22208
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National diabetes statistics report, 2020. Estimates of Diabetes and Its Burden in the United State; 2020. Available from: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statisticsreport.pdf. Accessed February 18, 2021.
   Google Scholar
• Bonora E, Trombetta M, Dauriz M, et al. Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9. BMJ Open Diabetes Res Care. 2020;8(1):e1549. doi:10.1136/bmjdrc-2020-001549
   Web of Science ®Google Scholar
• Lu LJ, Wang RJ, Ran L, et al. On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test. PLoS One. 2014;9(4):e93630. doi:10.1371/journal.pone.0093630
   PubMed Web of Science ®Google Scholar
• Ji G, Jin L, Wang R, et al. Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment. Med Oncol. 2013;30(3). doi:10.1007/s12032-013-0687-4
   Web of Science ®Google Scholar
• Liu J, Liu M, Chai Z, et al. Projected rapid growth in diabetes disease burden and economic burden in China: a spatio-temporal study from 2020 to 2030. Lancet Regional Health. 2023;33:100700. doi:10.1016/j.lanwpc.2023.100700
   Google Scholar
• Peairs KS, Barone BB, Snyder CF, et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol. 2011;29(1):40–46. doi:10.1200/JCO.2009.27.3011
   PubMed Web of Science ®Google Scholar
• Kang C, LeRoith D, Gallagher EJ. Diabetes, obesity, and breast cancer. Endocrinology. 2018;159(11):3801–3812. doi:10.1210/en.2018-00574
   PubMed Web of Science ®Google Scholar
• The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327–1334. doi:10.2337/dc09-9033
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Supplement_1):S13–S28. doi:10.2337/dc19-S002
   PubMedGoogle Scholar
• Zhou X, Ruan X, Hao L, et al. Optimal hemoglobin A1C cutoff value for diabetes mellitus and pre-diabetes in Pudong New Area, Shanghai, China. Prim Care Diabetes. 2018;12(3):238–244. doi:10.1016/j.pcd.2017.12.006
   PubMed Web of Science ®Google Scholar
• Wang S, Niu J, Zhao Z, et al. Detection of diabetes and prediabetes using glycosylated hemoglobin in Chinese adults living in Shanghai: a prospective analysis. J Diabetes. 2020;12(8):573–582. doi:10.1111/1753-0407.13028
   PubMed Web of Science ®Google Scholar
• Zhou B. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;1(15):83–96.
   Google Scholar
• World Health Organization. WHO Technical Report Series 894. Obesity: preventing and managing the global epidemic. Report of a WHO consultation; 2023.
   Google Scholar
• Hayashi T, Boyko EJ, Sato KK, et al. Patterns of Insulin Concentration During the OGTT Predict the Risk of Type 2 Diabetes in Japanese Americans. Diabetes Care. 2013;36(5):1229–1235. doi:10.2337/dc12-0246
   PubMed Web of Science ®Google Scholar
• Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294(1):E15–E26. doi:10.1152/ajpendo.00645.2007
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Nathan DM, Knowler WC, Edelstein SL, et al. HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial. Diabetes Care. 2014;37(11):e166655.
   Google Scholar
• Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the US population in 1988–2006. Diabetes Care. 2010;33(3):562–568. doi:10.2337/dc09-1524
   PubMed Web of Science ®Google Scholar
• Buell C, Kermah D, Davidson MB. Utility of A1C for Diabetes Screening in the 1999–2004 NHANES population. Diabetes Care. 2007;30(9):2233–2235. doi:10.2337/dc07-0585
   PubMed Web of Science ®Google Scholar
• Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care. 2001;24(3):465–471. doi:10.2337/diacare.24.3.465
   PubMed Web of Science ®Google Scholar
• Bennett CM, Guo M, Dharmage SC. HbA1c as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med. 2007;24(4):333–343. doi:10.1111/j.1464-5491.2007.02106.x
   PubMed Web of Science ®Google Scholar
• Tankova T, Chakarova N, Dakovska L, Atanassova I. Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes. Acta Diabetol. 2012;49(5):371–378. doi:10.1007/s00592-011-0334-5
   PubMed Web of Science ®Google Scholar
• Bao Y, Ma X, Li H, et al. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ. 2010;340(1):c2249. doi:10.1136/bmj.c2249
   PubMedGoogle Scholar
• Huang H, Peng G, Lin M, et al. The diagnostic threshold of HbA1c and impact of its use on diabetes prevalence-A population-based survey of 6898 Han participants from southern China. Prev Med. 2013;57(4):345–350. doi:10.1016/j.ypmed.2013.06.012
   PubMed Web of Science ®Google Scholar
• Liang K, Sun Y, Li W, et al. Diagnostic efficiency of hemoglobin A1c for newly diagnosed diabetes and prediabetes in community-based Chinese adults aged 40 years or older. Diabetes Technol Ther. 2014;16(12):853–857. doi:10.1089/dia.2014.0157
   PubMed Web of Science ®Google Scholar
• Ma H, Gao X, Lin HD, et al. Glycated haemoglobin in diagnosis of diabetes mellitus and pre-diabetes among middle-aged and elderly population: shanghai Changfeng study. Biomed Environ Sci. 2013;26(3):155–162. doi:10.3967/0895-3988.2013.03.001
   PubMed Web of Science ®Google Scholar
• Wu S, Yi F, Zhou C, et al. HbA1c and the diagnosis of diabetes and prediabetes in a middle‐aged and elderly Han population from northwest China. J Diabetes. 2013;5(3):282–290. doi:10.1111/1753-0407.12035
   PubMed Web of Science ®Google Scholar
• Yan ST, Xiao HY, Tian H, et al. The cutoffs and performance of glycated hemoglobin for diagnosing diabetes and prediabetes in a young and middle-aged population and in an elderly population. Diabet Res Clin Pract. 2015;109(2):238–245. doi:10.1016/j.diabres.2015.05.047
   PubMed Web of Science ®Google Scholar
• Zhou XH, Ji LN, Luo YY, Zhang XY, Han XY, Qiao Q. Performance of HbA1c for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing. Diabet Med. 2009;26(12):1262–1268. doi:10.1111/j.1464-5491.2009.02831.x
   PubMed Web of Science ®Google Scholar
• Ko GT, Chan JC, Yeung VT, et al. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care. 1998;21(8):1221–1225. doi:10.2337/diacare.21.8.1221
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016;23(1):27–47. doi:10.1016/j.cmet.2015.12.006
   PubMed Web of Science ®Google Scholar
• Yim C, Mansell K, Hussein N, Arnason T. Current cancer therapies and their influence on glucose control. World J Diabetes. 2021;12(7):1010–1025. doi:10.4239/wjd.v12.i7.1010
   PubMed Web of Science ®Google Scholar
• Abdel-Razeq H, Hashem H. Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia. Crit Rev Oncol/Hematol. 2020;145:102837. doi:10.1016/j.critrevonc.2019.102837
   PubMed Web of Science ®Google Scholar
• Su J, Chen T, Xu F, et al. Glycemic variability in normal glucose regulation subjects with elevated 1-h postload plasma glucose levels. Endocrine. 2014;46(2):241–248. doi:10.1007/s12020-013-0047-3
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani MA, Williams K, DeFronzo R, Stern M. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care. 2006;29(7):1613–1618. doi:10.2337/dc05-1711
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29(5):1130–1139. doi:10.2337/dc05-2179
   PubMed Web of Science ®Google Scholar
• Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev. 2015;95(3):727–748. doi:10.1152/physrev.00030.2014
   PubMed Web of Science ®Google Scholar
• Takahara M, Katakami N, Matsuoka TA, Noguchi M, Shimomura I. An inverse U-shaped association of late and peak insulin levels during an oral glucose load with glucose intolerance in a Japanese population: a cross-sectional study. Endocr J. 2015;62(2):217–226. doi:10.1507/endocrj.EJ14-0240
   PubMed Web of Science ®Google Scholar